Pharmacology at Penn State College of Medicine
The Department of Pharmacology will provide high quality training of the next generation of scientists and physicians and develop new diagnostic tests, medicines and delivery systems.
The Department of Pharmacology at Penn State College of Medicine is committed to teaching and research in the biomedical sciences. The department occupies 20,000 square of new laboratory space (all built since 2007) in the Hershey Center for Applied Research, Penn State Cancer Institute and Penn State Institute for Personalized Medicine. Research ranges from cell and molecular studies of cancer to biochemical/ pharmacological investigation of nervous system function (neurodegenerative disease, cognition and substance abuse) to whole animal studies of drug development.
Educationally, the department is involved in medical, graduate and allied health instruction and training. Former PhD trainees of the department are currently employed as professors, entrepreneurs, research scientists and administrators throughout the world. Our faculty serve as educational leaders within the university and across the nation. We are assistant deans, course directors, textbook authors and PhD program directors.
This is an exciting time in biomedical research and teaching. Join us for graduate school, for a postdoctoral position, as a faculty member. We are... Penn State Pharmacology.
Kent Vrana, PhD
Pharmacology Department Chair
Penn State College of Medicine
More about Pharmacology @ Penn State
Latest from Pharmacology
- Pharmacology Seminar Series/”Regulation of nuclear versus mitochondrial stress signaling in cancer biology and therapeutics by sphingolipid metabolism”
Apr 25, 2019 4:00 PM EDTRoom HCAR1103 – Hershey Center for Applied Research
- The Other Drug War: Psychoactive pharmaceuticals and addiction in U.S. history
May 1, 2019 4:00 PM EDTLecture Room B (Room C5621) – Penn State College of Medicine
- Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors.Desai D, Lauver M, Ostman A, Cruz L, Ferguson K, Jin G, Roper B, Brosius D, Lukacher A, Amin S, Buchkovich N. Bioorg Med Chem 2019 May 1;27(9):1795-1803
- Cross-talk between N-terminal and C-terminal domains in stromal interaction molecule 2 (STIM2) determines enhanced STIM2 sensitivity.Emrich SM, Yoast RE, Xin P, Zhang X, Pathak T, Nwokonko R, Gueguinou MF, Subedi KP, Zhou Y, Ambudkar IS, Hempel N, Machaca K, Gill DL, Trebak M. J Biol Chem 2019 Apr 19;294(16):6318-6332
- PARI (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells.Nicolae CM, O'Connor MJ, Schleicher EM, Song C, Gowda R, Robertson G, Dovat S, Moldovan GL. Oncogene 2019 Apr 9 : 10.1038/s41388-019-0810-x. [Epub ahead of print]
- Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kB-dependent P-glycoprotein upregulation.Tan SF, Dunton W, Liu X, Fox TE, Morad SAF, Desai D, Doi K, Conaway MR, Amin S, Claxton DF, Wang HG, Kester M, Cabot MC, Feith DJ, Loughran TP Jr. J Lipid Res 2019 Apr 8. pii: jlr.M091876 [Epub ahead of print]